1. Miller J, Kuchler H. BioNTech and Pfizer plan to supply 700m more Covid vaccine doses. Financial Times 2021 Jan 12. https://www.ft.com/content/338fa31b-6b4d-4184-b41b-98388652a943.
2. AstraZeneca. AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19. 23 Nov 2020. https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html.
3. Kansteiner F. Moderna dials up low-end COVID-19 vaccine supply estimate, setting sights on 1B doses in 2021. Fierce Pharma 2021 Jan 5. https://www.fiercepharma.com/manufacturing/moderna-dials-up-low-end-vaccine-supply-estimate-setting-sights-1-billion-doses-2021.
4. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
5. World Health Organization. Covax announces additional deals to access promising covid-19 vaccine candidates; plans global rollout starting Q1 2021. 18 Dec 2020. https://www.who.int/news/item/18-12-2020-covax-announces-additional-deals-to-access-promising-covid-19-vaccine-candidates-plans-global-rollout-starting-q1-2021.